Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies
Aude Desnoyer, Sophie Broutin, J Delahousse, Christophe Maritaz, Louis Blondel, Olivier Mir, Nathalie Chaput, Angélo Paci
Topics & Concepts
PembrolizumabNivolumabMonoclonal antibodyImmunogenicityPharmacodynamicsImmune systemMedicineAtezolizumabAntibodyImmunologyPharmacokineticsEpitopePharmacologyImmunotherapyCytotoxic T cellBiologyBiochemistryIn vitroCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionCAR-T cell therapy research